Microbubbles May Boost Response to Transarterial Radioembolization for the Most Common Form of Liver Cancer
In a first-of-its-kind clinical trial, researchers at Thomas Jefferson University demonstrated the safety of combining ultrasound-triggered microbubble destruction and transarterial radioembolization (TARE) to treat patients with hepatocellular carcinoma — and found that combining the therapies was nearly twice as effective as TARE alone.
For the Radiological Society of North America (RSNA), the COVID-19 pandemic has served as a catalyst to enhance the practice of radiology.
Recent experimental research shows a promising outlook for clinical trials in boys.
Clinicians spent over a year researching the unique risks of infants born to women with a confirmed SARS-CoV-2 infection. While some dangers have been identified, other study findings are promising.
Robotic surgery can improve the patient experience, but this minimally-invasive technique also has potential to enhance quality of life for clinicians.